July 11 (Reuters) - Intellipharmaceutics International Inc IPCI.TO
* Intellipharmaceutics announces second quarter 2017 results
* Qtrly revenues more than tripled to $2.0 million from $0.6 million
* Q2 loss per share $0.06
* Had cash of $1.5 million as at May 31, 2017 compared to $2.4 million as at February 28, 2017
* Currently expect to satisfy our operating cash requirements until September 2017 Source text for Eikon: ID:nGNXOAARQa Further company coverage: IPCI.TO